Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$4.17 - $7.09 $23,848 - $40,547
-5,719 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$5.87 - $7.85 $9,157 - $12,246
1,560 Added 37.51%
5,719 $34,000
Q2 2021

Aug 16, 2021

BUY
$6.69 - $9.0 $9,432 - $12,690
1,410 Added 51.29%
4,159 $31,000
Q1 2021

May 17, 2021

BUY
$8.26 - $11.4 $2,345 - $3,237
284 Added 11.52%
2,749 $23,000
Q4 2020

Feb 19, 2021

BUY
$8.21 - $18.59 $10,057 - $22,772
1,225 Added 98.79%
2,465 $21,000
Q3 2020

Nov 13, 2020

BUY
$11.33 - $19.81 $14,049 - $24,564
1,240 New
1,240 $23,000

Others Institutions Holding MESO

About MESOBLAST LTD


  • Ticker MESO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 147,316,000
  • Market Cap $1.57B
  • Description
  • Mesoblast Limited, a biopharmaceutical company, develops and commercializes allogeneic cellular medicines in the United States, Australia, Singapore, the United Kingdom, and Switzerland. The company offers products in the areas of cardiovascular, spine orthopedic disorder, oncology, hematology, and immune-mediated and inflammatory diseases. Its ...
More about MESO
Track This Portfolio

Track Walled Lake Planning & Wealth Management, LLC Portfolio

Follow Walled Lake Planning & Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walled Lake Planning & Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walled Lake Planning & Wealth Management, LLC with notifications on news.